Leading minimally-invasive technologies for diagnosing and treating a variety of heart and vascular conditions

A new
lease on life

We’re committed to advancing cardiology through less invasive technologies that improve outcomes, deliver care to more patients, reduce costs, and help millions live healthier lives.

Delivering Meaningful Innovation

A Pioneering Alternative to Blood Thinners. The WATCHMAN™ Left Atrial Appendage Closure Device is the only FDA-approved heart implant proven to reduce stroke risk in patients with non-valvular atrial fibrillation who need an alternative to long-term blood thinners. The WATCHMAN device is covered by Medicare and Medicaid Services for patients meeting certain coverage criteria.

Designed to Optimize TAVR. The LOTUS Edge™ Aortic Valve System is a transcatheter aortic valve replacement (TAVR) technology that is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement via open heart surgery.

The SENTINEL™ Cerebral Protection System (CPS) is the first and only commercially available device in the U.S. offering protected TAVR – proven embolic protection against the risk of TAVR-related stroke

Healing with Confidence. The SYNERGY™ Bioabsorbable Polymer Stent System is the first and only FDA-approved stent with a fast-absorbing bioabsorbable polymer coating to enable rapid healing and provide freedom from long-term polymer exposure.